Connecting medical imaging leaders to the latest industry news, best practices, and AHRA happenings.
By Adrienne Dresevic, Esq. and Arturo Trafny, Esq. of The Health Law Partners, P.C.
The U.S. Equal Employment Opportunity Commission (EEOC) recently updated its guidance regarding the COVID-19 public health emergency (PHE) and its impact on certain equal employment opportunity laws (the “COVID-19 Guidance”).
By Capitol Associates, Inc.
The House of Representatives is voting on R. 6800, the HEROES Act, a $3 trillion COVID-19 relief bill introduced by House Democrats. If passed, the bill will not receive consideration in the Senate. However, it could serve as the basis for future negotiations on bipartisan legislation. The bill is not expected to receive much Republican support if any. There are also some Democrats who oppose the bill.
By Capitol Associates, Inc.
CMS published a new “toolkit” of best practices for nursing homes. The document is intended to serve as a catalogue of resources dedicated to addressing the specific challenges facing nursing homes as they combat COVID-19.
By Capitol Associates, Inc.
HHS will provide some courses of the Remdesivir treatment to states to distribute. According to the announcement, Gilead Sciences is supplying approximately 607,000 vials of the experimental treatment over the next six weeks to treat an estimated 78,000 hospitalized COVID-19 patients. The donation to the United States is part of 1.5 million vials of Remdesivir the company is donating worldwide.
By Capitol Associates, Inc.
On April 30th, the Centers for Medicare and Medicaid Services (CMS) announced a number of new blanket waivers and regulatory flexibilities. The announcement includes new Medicare telehealth coverage flexibilities. All of the telehealth policies in the rule are retroactive to March 1, 2020. These policies will last through the duration of the COVID-19 public health emergency.
